Program by the pharmaceutical company Eli Lilly and Company aimed at supporting Investigator-Initiated Studies (IIS).

Through this program, financial support and/or study drugs will be provided for studies that are initiated, designed, and sponsored by investigators external to the company.

Areas of interest (more information): https://www.lillyinvestigatorresearch.com/AreaofInterest

• Oncology

• Immunology

• Pain (including headache and chronic pain)

• Neurodegenerative diseases

• Obesity and diabetes

The call is open to all interested healthcare professionals and researchers.

Applicants must have the ability to design and conduct scientific research, as well as meet the institutional requirements of the site where the study will be conducted and comply with all relevant laws, regulations, and research guidelines.

In case of interest, please click on 'm'interessa' and we will contact you.